Itafos (CVE:IFOS) Stock Price Down 0.8% – Should You Sell?

Itafos Inc. (CVE:IFOSGet Free Report) shares dropped 0.8% during trading on Tuesday . The stock traded as low as C$2.37 and last traded at C$2.40. 38,954 shares were traded during trading, a decline of 80% from the average daily volume of 199,024 shares. The stock had previously closed at C$2.42.

Wall Street Analyst Weigh In

Separately, Raymond James Financial cut Itafos from a “strong-buy” rating to an “outperform” rating and reduced their target price for the stock from C$5.50 to C$4.50 in a report on Monday, May 11th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat, Itafos presently has an average rating of “Buy” and a consensus target price of C$4.50.

View Our Latest Analysis on Itafos

Itafos Price Performance

The company has a market cap of C$467.47 million, a P/E ratio of 5.71 and a beta of 0.04. The firm’s 50-day moving average is C$2.56 and its two-hundred day moving average is C$3.07. The company has a debt-to-equity ratio of 19.58, a current ratio of 2.71 and a quick ratio of 0.72.

About Itafos

(Get Free Report)

Itafos Inc operates as a phosphate and specialty fertilizer company. It operates through Conda, Arrais, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, hydrofluorosilicic acid, direct application phosphate rock, single superphosphate (SSP), SSP with micronutrients, and sulfuric acid. It also owns interests in the Farim, a phosphate mine project situated in Farim, Guinea-Bissau; Araxá, a rare earth element and niobium mine and extraction plant project that is situated in Minas Gerais, Brazil; Arraias, an integrated phosphate fertilizer project located in Tocantins, Brazil; and Santana, an integrated phosphate mine and fertilizer plant project located in Pará, Brazil.

Read More

Receive News & Ratings for Itafos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itafos and related companies with MarketBeat.com's FREE daily email newsletter.